pI: 8.8929 |
Length (AA): 267 |
MW (Da): 28980 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 7 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
12 | 267 | 1ef8 (A) | 2 | 261 | 27.00 | 0 | 1 | 1.34 | -0.91 |
15 | 241 | 2a7k (A) | 1 | 230 | 25.00 | 0 | 1 | 1.28 | -1.59 |
27 | 266 | 1mj3 (A) | 50 | 289 | 53.00 | 0 | 1 | 1.6 | -0.98 |
10 | 267 | 3moy (A) | 2 | 259 | 44.00 | 0 | 1 | 1.54089 | -0.56 |
15 | 267 | 3h81 (A) | 26 | 278 | 49.00 | 0 | 1 | 1.57917 | -0.63 |
16 | 267 | 2pbp (A) | 7 | 258 | 45.00 | 0 | 1 | 1.53092 | -0.46 |
24 | 208 | 1nzy (A) | 13 | 204 | 31.00 | 0 | 1 | 1.13498 | -1.01 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_128562)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_30520 | Probable enoyl-CoA hydratase, mitochondrial |
Caenorhabditis elegans | CELE_Y105E8A.4 | Protein ECH-7 |
Caenorhabditis elegans | CELE_T05G5.6 | Protein ECH-6 |
Dictyostelium discoideum | DDB_G0285071 | enoyl Coenzyme A hydratase, mitochondrial |
Drosophila melanogaster | Dmel_CG6543 | CG6543 gene product from transcript CG6543-RA |
Escherichia coli | b1393 | 2,3-dehydroadipyl-CoA hydratase |
Echinococcus granulosus | EgrG_000702200 | enoyl coenzyme A hydratase |
Echinococcus multilocularis | EmuJ_000702200 | enoyl coenzyme A hydratase |
Homo sapiens | ENSG00000127884 | enoyl CoA hydratase, short chain, 1, mitochondrial |
Leishmania braziliensis | LbrM.29.2280 | enoyl-CoA hydratase/isomerase-like protein |
Leishmania donovani | LdBPK_292420.1 | enoyl-CoA hydratase/isomerase-like protein |
Leishmania infantum | LinJ.29.2420 | enoyl-CoA hydratase/isomerase-like protein |
Leishmania major | LmjF.29.2310 | enoyl-CoA hydratase/isomerase-like protein |
Leishmania mexicana | LmxM.08_29.2310 | enoyl-CoA hydratase/isomerase-like protein |
Loa Loa (eye worm) | LOAG_10253 | hypothetical protein |
Mycobacterium leprae | ML2402 | PROBABLE ENOYL-CoA HYDRATASE ECHA8 (ENOYL HYDRASE) (UNSATURATED ACYL-CoA HYDRATASE) (CROTONASE) |
Mus musculus | ENSMUSG00000025465 | enoyl Coenzyme A hydratase, short chain, 1, mitochondrial |
Mycobacterium tuberculosis | Rv1070c | Probable enoyl-CoA hydratase EchA8 (enoyl hydrase) (unsaturated acyl-CoA hydratase) (crotonase) |
Mycobacterium ulcerans | MUL_3889 | enoyl-CoA hydratase EchA16 |
Mycobacterium ulcerans | MUL_0126 | enoyl-CoA hydratase, EchA8 |
Mycobacterium ulcerans | MUL_2758 | enoyl-CoA hydratase, EchA8_5 |
Mycobacterium ulcerans | MUL_0210 | enoyl-CoA hydratase |
Mycobacterium ulcerans | MUL_0310 | enoyl-CoA hydratase, EchA8_2 |
Mycobacterium ulcerans | MUL_3888 | enoyl-CoA hydratase EchA11 |
Neospora caninum | NCLIV_012140 | enoyl-CoA hydratase/isomerase family domain- containing protein, putative |
Schmidtea mediterranea | mk4.000573.00 | |
Trypanosoma brucei gambiense | Tbg972.3.5430 | enoyl-CoA hydratase, mitochondrial precursor, putative |
Trypanosoma brucei | Tb927.3.4850 | enoyl-CoA hydratase, mitochondrial precursor, putative |
Trypanosoma congolense | TcIL3000_0_42580 | enoyl-CoA hydratase, mitochondrial precursor, putative |
Trypanosoma cruzi | TcCLB.508153.130 | enoyl-CoA hydratase, mitochondrial precursor, putative |
Trypanosoma cruzi | TcCLB.508185.10 | enoyl-CoA hydratase, mitochondrial precursor, putative |
Toxoplasma gondii | TGME49_317705 | enoyl-CoA hydratase/isomerase family protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu1087 | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb927.3.4850 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.4850 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.4850 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.3.4850 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b1393 | Escherichia coli | non-essential | goodall |
CELE_T05G5.6 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_T05G5.6 | Caenorhabditis elegans | slow growth | wormbase |
TGME49_317705 | Toxoplasma gondii | Essentiality uncertain | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.2